Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia(Vita-Salute San Raffaele University), Mark Peakman(Sanofi (France)), Richard A. Oram(University of Exeter), Emanuele Bosi(Vita-Salute San Raffaele University), David Skibinski(Agency for Science, Technology and Research), Carla J. Greenbaum(Society of Interventional Radiology), Kevan C. Herold(Yale University), María J. Redondo(Baylor College of Medicine), Eoin McKinney(University of Cambridge), Tomi Pastinen(Children's Mercy Hospital), Martin J. Hessner(Medical College of Wisconsin), Noel G. Morgan(University of Exeter), Desmond Schatz(University of Florida), Linda A. DiMeglio(Urology of Indiana), Todd M. Brusko(University of Florida), S. Alice Long(Benaroya Research Institute), Mark A. Atkinson(University of Florida), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Alessandra Petrelli(University of Milan), Xiaoning Qian(Brookhaven National Laboratory), Markus Lundgren(Lund University), Peter A. Gottlieb(University of Colorado Health), Jeffrey P. Krischer(University of South Florida), Michael C. Peters(University of California, San Francisco), Mark S. Anderson(University of California, San Francisco), Laura M. Jacobsen(University of Florida), Stephen E. Gitelman(University of California, San Francisco), Dorothy Becker(Children's Hospital of Pittsburgh), Mikael Knip(Åbo Akademi University), Polly J. Bingley(University of Bristol), Simi Ahmed(Breakthrough T1D)
Cited by 350
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k